4 May 2026 in SSRN Electronic Journal
BackgroundSchizophrenia is a chronic mental disorder that requires lifelong treatment. Medication nonadherence contributes to poor medical outcomes; the ability to predict a patient’s adherence trajectory cannot be understated in forestalling the negative effects of nonadherence. This study aimed to identify antipsychotic adherence latent classes among patients diagnosed with schizophrenia or schizoaffective disorder and evaluate predictors of adherence latent classes. Healthcare utilization, including hospitalizations and emergency department visits across adherence trajectories, was also evaluated.MethodsThis study utilized South Carolina Medicaid claims for beneficiaries diagnosed with schizophrenia or schizoaffective disorder from 2014 to 2020 using a latent class mixture modeling framework. This consists of two submodels: a membership model that categorizes patients into adherence classes and a longitudinal model that characterizes adherence trajectories over time within each adherence class.ResultsA total of 2,870 eligible patients were included in the study, with 1,707 males and 1,163 females. Four distinct adherence trajectories were identified: most adherent (56% of the population), early drop-off (12%), initial adherence followed by an increase (8%), least adherent (24%). The impact of predictors and frequency of healthcare utilization outcomes varied across classes. Time consistently demonstrated a significant impact on trajectory shapes.ConclusionFour distinct trajectories for adherence were identified among South Carolina’s Medicaid beneficiaries. Significant patient characteristics that determined class memberships and adherence trajectories varied across classes.